These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22938497)

  • 1. Experimental strategies for induction of gastric adenocarcinomas under long-term proton pump inhibitor administration and Helicobacter pylori infection.
    Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
    Asian Pac J Cancer Prev; 2012; 13(6):3005-6. PubMed ID: 22938497
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
    Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
    Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.
    Kinoshita S; Nishizawa T; Mori H; Kikuchi M
    J Clin Pharm Ther; 2019 Jun; 44(3):493. PubMed ID: 30773665
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of glandular stomach cancers in Helicobacter pylori-infected Mongolian gerbils by 1-nitrosoindole-3-acetonitrile.
    Matsubara S; Takasu S; Tsukamoto T; Mutoh M; Masuda S; Sugimura T; Wakabayashi K; Totsuka Y
    Int J Cancer; 2012 Jan; 130(2):259-66. PubMed ID: 21387296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.
    Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
    Gut; 2011 May; 60(5):624-30. PubMed ID: 21097844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil.
    Fox JG; Kuipers EJ
    Gut; 2011 May; 60(5):567-8. PubMed ID: 21330575
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of duodenogastric reflux on N-methyl-N'-nitro-N-nitrosoguanidine-induced glandular stomach tumorigenesis in Helicobacter pylori-infected Mongolian gerbils.
    Tanaka Y; Osugi H; Morimura K; Takemura M; Ueno M; Kaneko M; Fukushima S; Kinoshita H
    Oncol Rep; 2004 May; 11(5):965-71. PubMed ID: 15069533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
    Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
    Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gastric neuroendocrine tumor after prolonged use of proton pump inhibitors.
    Prado PHT; Paula RV; de Faria ATR; Silva BL; Ardengh JC
    Rev Esp Enferm Dig; 2023 Apr; 115(4):209-210. PubMed ID: 36148661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
    Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
    Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Helicobacter pylori Infection on gastric mucin expression.
    Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
    Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
    Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
    Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
    Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperplastic polyp with neoplastic transformation in a patient with atrophic gastritis and multiple gastric neuroendocrine tumors].
    Moura EG; Domingos TA; Alvarado H; Iriya K; Kishi HS; Martins BC; Moura ET; P PS
    Rev Gastroenterol Mex; 2012; 77(2):96-8. PubMed ID: 22658549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and gastric cancer: a population-based cohort study.
    Patel J; Berezowski I; Janapala RN; Pourmand A
    Gut; 2022 May; 71(5):1039-1041. PubMed ID: 34261754
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
    Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
    Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Suzuki H; Matsuzaki J
    Gut; 2018 Nov; 67(11):2071-2072. PubMed ID: 29247066
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
    Vakil N
    Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.